Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Apr 16, 2010


Cell Biosciences this week launched the NanoPro 100 system and FluorChem E Digital Darkroom.

The NanoPro 100 is a benchtop version of the NanoPro CB 1000, which was launched a year ago (PM 04/16/09). The NanoPro 100 offers the same analytical capability as the CB 1000 but is designed for lower-throughput laboratories and individual investigators, Cell Biosciences said in a statement.

The system sells for under $100,000.

The FluroChem E Digital Darkroom is the first of Cell Biosciences' next-generation imaging products, the company said, and incorporates state-of-the-art CCD technology and intuitive touch-screen control "for effortless analysis of chemiluminescent, colorimetric, and UV-fluorescent samples." The instrument, it added, "sets a new standard" for high-performance chemiluminescent Western blot and gel imaging.

Proteome Software this week released Scaffold 3.0 for MS/MS visualization and validation.

The software's new SF3 file format allows for "faster data access and unlimited file scalability," the company said in a statement. Its new Venn diagram functionality makes advanced filtering and navigation quick and easy, Proteome Software added, and new statistical techniques improve identification rates with high mass accuracy data.

TTP LabTech this week launched the Mirrorball, a high sensitivity laser scanning microplate cytometer for antibody discovery.

The instrument is available in three upgradeable configurations, with the highest specification offering dual laser excitation, 488 nm and 640 nm, four fluorescence channels and a single laser scatter channel.

Mirrorball's laser scatter channel enables label-free object recognition independent of fluorescence, "which can be combined with concurrent collection of fluorescence data for even greater sensitivity in multiplexed assays," TTP LabTech said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.